STOCK TITAN

Bachem Annual General Meeting 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Bachem (SIX: BANB) held its Annual General Meeting 2026 where shareholders approved all board proposals. A dividend of CHF 0.90 per share was approved, payable on May 6, 2026; last trading day with entitlement is April 30, 2026 and shares trade ex-dividend as of May 4, 2026.

Attendance was 78.3% of 74,977,940 eligible shares. Board members were re-elected; Helma Wennemers was newly elected Chair of the Compensation Committee. Forvis Mazars SA, Zurich was appointed auditor for 2026. A full list of resolutions and the financial calendar were published.

Loading...
Loading translation...

Positive

  • Dividend of CHF 0.90 per share approved, payable May 6, 2026
  • High shareholder participation: 78.3% of 74,977,940 eligible shares present
  • Board continuity: All directors re-elected for another year
  • Appointment of Forvis Mazars SA, Zurich as auditor for 2026

Negative

  • None.

  • All proposals of the Board of Directors approved.
  • Dividend of CHF 0.90 per share.

Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present.

The Annual General Meeting approved a dividend of CHF 0.90 per share. The dividend will be paid on May 6, 2026. The last trading day entitled to receive the dividend is April 30, 2026. As of May 4, 2026, the shares will be traded ex-dividend.

Both the Chairman and the other members of the Board of Directors were re-elected for a further year. Helma Wennemers was newly elected Chair of the Compensation Committee, replacing Kuno Sommer, who stepped down from the committee. The existing members of the Compensation Committee, Nicole Grogg Hötzer and Alex Fässler, were re-elected for a further year.

The shareholders approved the annual report, the financial statements of Bachem Holding AG, the consolidated financial statements for the business year 2025, as well as the appropriation of retained earnings and reserves from capital contributions and the total amount of the annual compensation paid to the Board of Directors and to the Corporate Executive Committee. Further, the shareholders approved the sustainability report and, in a consultative vote, the remuneration report. 

Forvis Mazars SA, Zurich was appointed by the Annual General Meeting as auditor of Bachem Holding AG for the business year 2026. 

A detailed list of all resolutions will be made available at https://www.bachem.com/about-bachem/investor-hub/.

Financial Calendar

May 6, 2026Payout date for dividend
  
July 30, 2026Publication of Half-Year Report 2026
  
November 26, 2026Capital Markets Day
  
March 4, 2027Publication of Annual Report 2026; Media and Analyst conference
  
April 28, 2027Annual General Meeting (financial year 2026)


About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.

For more information

Media
Patrick Barth
Head Group Communications
Tel.: +41 58 595 4522
Email: media@bachem.com
Investors
Barbora Blaha
Head Investor Relations
Tel.: +41 58 595 0573
Email: ir@bachem.com

 

This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294924

FAQ

What dividend did Bachem (BANB) approve at the Annual General Meeting 2026?

The AGM approved a dividend of CHF 0.90 per share. According to Bachem, the dividend will be paid on May 6, 2026, with the last trading day entitled to receive it on April 30, 2026.

When will Bachem (BANB) shares trade ex-dividend after the 2026 AGM?

Bachem shares will trade ex-dividend as of May 4, 2026. According to Bachem, shareholders of record before April 30, 2026 remain entitled to the CHF 0.90 dividend.

Who was elected to the Compensation Committee at Bachem's 2026 AGM (BANB)?

Helma Wennemers was newly elected Chair of the Compensation Committee. According to Bachem, Nicole Grogg Hötzer and Alex Fässler were re-elected as committee members.

What auditor did Bachem (BANB) appoint for the business year 2026?

The AGM appointed Forvis Mazars SA, Zurich as auditor for 2026. According to Bachem, this appointment covers the financial year 2026 and related audit responsibilities.

What shareholder turnout was reported at Bachem's Annual General Meeting 2026 (BANB)?

Shareholder participation was reported at 78.3% of 74,977,940 eligible shares. According to Bachem, that represents the proportion of eligible shares present at the AGM when resolutions were voted.